a transformative partnership agilon health partners with primary care physicians to define a new standard of quality, efficiency and patient experience. we bring the people, solutions, capital and technology necessary to ensure their long-term success and to bring back the joy of practicing medicine. critical care we believe that every member of our team plays a critical role in transforming care for our patients. our customer service teams are the front line for physicians and patients navigating the system and, without our claims processing departments, our health plan partners and provider networks couldn’t do their jobs. no matter what your role is at agilon health, you can and will make a difference in the lives of the seniors and medicaid populations we serve. our culture and passion has already been embraced by nearly 500 employees in three states. and we are excited to welcome new members to the team as more physicians and patients experience the difference agilon health can ma
Company profile
Ticker
AGL
Exchange
Website
CEO
Steve Sell
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Agilon Health Topco, Inc.
SEC CIK
Corporate docs
Subsidiaries
Agilon Equity PPCP Holdings, LLC • agilon health Catalyst Health Network ACO, Inc. • agilon health Coastal DCE, Inc. • agilon health Coastal ACO, Inc. • agilon health Columbus Ohio DCE, Inc. • Agilon Health Holdings, Inc. • Agilon health Kentucky ACO, Inc. • agilon health of California, Inc. • agilon health management, inc. • Agilon Health India Private Limited ...
IRS number
371915147
AGL stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
18 Apr 24
DEFA14A
Additional proxy soliciting materials
18 Apr 24
DEF 14A
Definitive proxy
18 Apr 24
10-K
2023 FY
Annual report
27 Feb 24
8-K
Results of Operations and Financial Condition
27 Feb 24
8-K
Departure of Directors or Certain Officers
8 Feb 24
8-K
Departure of Directors or Certain Officers
5 Jan 24
8-K
Revised 2023 expectations and early outlook for 2024 reflect higher medical
5 Jan 24
8-K
Regulation FD Disclosure
14 Nov 23
10-Q
2023 Q3
Quarterly report
2 Nov 23
Transcripts
AGL
Earnings call transcript
2023 Q4
27 Feb 24
AGL
Earnings call transcript
2023 Q3
2 Nov 23
AGL
Earnings call transcript
2023 Q2
3 Aug 23
AGL
Earnings call transcript
2023 Q1
9 May 23
AGL
Earnings call transcript
2022 Q4
1 Mar 23
AGL
Earnings call transcript
2022 Q3
3 Nov 22
AGL
Earnings call transcript
2022 Q2
6 Aug 22
AGL
Earnings call transcript
2022 Q1
8 May 22
AGL
Earnings call transcript
2021 Q4
4 Mar 22
AGL
Earnings call transcript
2022 Q4
1 Mar 22
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 178.54 mm | 178.54 mm | 178.54 mm | 178.54 mm | 178.54 mm | 178.54 mm |
Cash burn (monthly) | 7.55 mm | 32.16 mm | 16.32 mm | 11.14 mm | 4.34 mm | 12.08 mm |
Cash used (since last report) | 50.41 mm | 214.81 mm | 109.03 mm | 74.42 mm | 28.98 mm | 80.70 mm |
Cash remaining | 128.13 mm | -36.26 mm | 69.52 mm | 104.12 mm | 149.56 mm | 97.84 mm |
Runway (months of cash) | 17.0 | -1.1 | 4.3 | 9.3 | 34.5 | 8.1 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 190 |
Opened positions | 31 |
Closed positions | 35 |
Increased positions | 88 |
Reduced positions | 42 |
13F shares | Current |
---|---|
Total value | 7.97 tn |
Total shares | 644.81 mm |
Total puts | 590.30 k |
Total calls | 769.00 k |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
CD&R Vector | 194.61 mm | $0.00 |
Clayton, Dubilier & Rice | 100.00 mm | $1.78 tn |
FMR | 60.78 mm | $1.08 tn |
Capital World Investors | 51.41 mm | $912.96 bn |
MS Morgan Stanley | 44.82 mm | $795.99 bn |
Wellington Management | 41.32 mm | $733.82 bn |
Vanguard | 28.36 mm | $503.59 bn |
Capital Research Global Investors | 19.60 mm | $348.03 bn |
T. Rowe Price Investment Management | 14.67 mm | $260.60 bn |
BLK Blackrock | 13.45 mm | $238.81 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Apr 24 | Steven Sell | Common Stock | Grant | Acquire A | No | No | 0 | 252,243 | 0.00 | 336,322 |
15 Apr 24 | Steven Sell | Options Common Stock | Grant | Acquire A | No | No | 4.46 | 415,130 | 1.85 mm | 415,130 |
15 Apr 24 | Benjamin Shaker | Common Stock | Grant | Acquire A | No | No | 0 | 196,189 | 0.00 | 454,921 |
15 Apr 24 | Benjamin Shaker | Options Common Stock | Grant | Acquire A | No | No | 4.46 | 322,879 | 1.44 mm | 322,879 |
15 Apr 24 | Veeral Desai | Common Stock | Grant | Acquire A | No | No | 0 | 196,189 | 0.00 | 502,830 |
15 Apr 24 | Veeral Desai | Options Common Stock | Grant | Acquire A | No | No | 4.46 | 322,879 | 1.44 mm | 322,879 |
15 Apr 24 | Timothy Gertsch | Common Stock | Grant | Acquire A | No | No | 0 | 42,041 | 0.00 | 59,162 |
15 Apr 24 | Timothy Gertsch | Options Common Stock | Grant | Acquire A | No | No | 4.46 | 69,189 | 308.58 k | 69,189 |
15 Apr 24 | Girish Venkatachaliah | Common Stock | Grant | Acquire A | No | No | 0 | 112,108 | 0.00 | 152,058 |
15 Apr 24 | Girish Venkatachaliah | Options Common Stock | Grant | Acquire A | No | No | 4.46 | 184,502 | 822.88 k | 184,502 |
News
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
2 Apr 24
Barclays Initiates Coverage On Agilon Health with Underweight Rating, Announces Price Target of $5
6 Mar 24
Truist Securities Maintains Hold on Agilon Health, Lowers Price Target to $7.5
29 Feb 24
Benchmark Maintains Buy on Agilon Health, Lowers Price Target to $9
29 Feb 24
Evercore ISI Group Maintains In-Line on Agilon Health, Lowers Price Target to $6
28 Feb 24
Press releases
AGL Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Lawsuit Against agilon health, inc. on Their Behalf (AGL)
19 Apr 24
DEADLINE ALERT for SSRM, AGL, CC, SHLS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
18 Apr 24
Shareholders that lost money on agilon health, inc. (AGL) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
18 Apr 24
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of agilon health, inc. - AGL
17 Apr 24
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Agilon, NBH, Shoals, and Blue and Encourages Investors to Contact the Firm
17 Apr 24